{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:29:05Z","timestamp":1788640145802,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI170116"],"award-info":[{"award-number":["R01 AI170116"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund","doi-asserted-by":"publisher","award":["17161162"],"award-info":[{"award-number":["17161162"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cross-reactive antibodies with Fc receptor (FcR) effector functions may mitigate pandemic virus impact in the absence of neutralizing antibodies. In this exploratory study, we use serum from a randomized placebo-controlled trial of seasonal trivalent influenza vaccination in children (NCT00792051) conducted at the onset of the 2009 H1N1 pandemic (pH1N1) and monitored for infection. We found that seasonal vaccination increases pH1N1 specific antibodies and FcR effector functions. Furthermore, prospective baseline antibody profiles after seasonal vaccination, prior to pH1N1 infection, show that unvaccinated uninfected children have elevated ADCC effector function, Fc\u03b3R3a and Fc\u03b3R2a binding antibodies to multiple pH1N1 proteins, past seasonal and avian (H5, H7 and H9) strains. Whereas, children that became pH1N1 infected after seasonal vaccination have antibodies focussed to seasonal strains without FcR functions, and greater aggregated HA-specific profiles for IgM and IgG3. Modeling to predict infection susceptibility, ranked baseline hemagglutination antibody inhibition as the highest contributor to lack of pH1N1 infection, in combination with features that include pH1-IgG1, H1-stem responses and FcR binding to seasonal vaccine and pH1 proteins. Thus, seasonal vaccination can have benefits against pandemic influenza viruses, and some children already have broadly reactive antibodies with Fc potential without vaccination and may be considered \u2018elite influenza controllers\u2019.<\/jats:p>","DOI":"10.1038\/s41467-024-47590-0","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T12:01:54Z","timestamp":1713009714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-9625","authenticated-orcid":false,"given":"Janice Z.","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7541-4262","authenticated-orcid":false,"given":"Haogao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milla R.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0823-7577","authenticated-orcid":false,"given":"Raghavan","family":"Varadarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6881-6552","authenticated-orcid":false,"given":"Nisha","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-5995","authenticated-orcid":false,"given":"Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2503-6283","authenticated-orcid":false,"given":"Gabriel M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-7953","authenticated-orcid":false,"given":"Leo L. M.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5037-6776","authenticated-orcid":false,"given":"Tim","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0020-9704","authenticated-orcid":false,"given":"Amy W.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-7154","authenticated-orcid":false,"given":"Benjamin J.","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7314-840X","authenticated-orcid":false,"given":"Nancy H. L.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0768-9926","authenticated-orcid":false,"given":"Sophie A.","family":"Valkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,13]]},"reference":[{"key":"47590_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/cid\/cis518","volume":"55","author":"BJ Cowling","year":"2012","unstructured":"Cowling, B. J. et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clin. Infect. Dis. 55, 695\u2013702 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"47590_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/infdis\/jit294","volume":"208","author":"S Jegaskanda","year":"2013","unstructured":"Jegaskanda, S. et al. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1. J. Infect. Dis. 208, 1051\u20131061 (2013).","journal-title":"J. Infect. Dis."},{"key":"47590_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/infdis\/jiy103","volume":"218","author":"EJ Erbelding","year":"2018","unstructured":"Erbelding, E. J. et al. A universal influenza vaccine: the strategic plan for the National Institute of Allergy and Infectious Diseases. J. Infect. Dis. 218, 347\u2013354 (2018).","journal-title":"J. Infect. Dis."},{"key":"47590_CR4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","volume":"30","author":"S Black","year":"2011","unstructured":"Black, S. et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr. Infect. Dis. J. 30, 1081\u20131085 (2011).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"47590_CR5","first-page":"767","volume":"70","author":"D Hobson","year":"1972","unstructured":"Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. 70, 767\u2013777 (1972).","journal-title":"J. Hyg."},{"key":"47590_CR6","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","volume":"25","author":"S Ng","year":"2019","unstructured":"Ng, S. et al. Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat. Med. 25, 962\u2013967 (2019).","journal-title":"Nat. Med."},{"key":"47590_CR7","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","volume":"190","author":"S Jegaskanda","year":"2013","unstructured":"Jegaskanda, S. et al. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J. Immunol. 190, 1837\u20131848 (2013).","journal-title":"J. Immunol."},{"key":"47590_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/infdis\/jiv181","volume":"212","author":"M Terajima","year":"2015","unstructured":"Terajima, M., Co, M. D., Cruz, J. & Ennis, F. A. High antibody-dependent cellular cytotoxicity antibody titers to H5N1 and H7N9 avian influenza A viruses in healthy US adults and older children. J. Infect. Dis. 212, 1052\u20131060 (2015).","journal-title":"J. Infect. Dis."},{"key":"47590_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.vaccine.2016.11.082","volume":"35","author":"RD de Vries","year":"2017","unstructured":"de Vries, R. D. et al. Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection. Vaccine 35, 238\u2013247 (2017).","journal-title":"Vaccine"},{"key":"47590_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.vaccine.2019.10.093","volume":"38","author":"MK Smatti","year":"2020","unstructured":"Smatti, M. K., Nasrallah, G. K., Al Thani, A. A. & Yassine, H. M. Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes. Vaccine 38, 815\u2013821 (2020).","journal-title":"Vaccine"},{"key":"47590_CR11","first-page":"818","volume":"215","author":"S Jegaskanda","year":"2017","unstructured":"Jegaskanda, S. et al. Induction of H7N9-cross-reactive antibody-dependent cellular cytotoxicity antibodies by human seasonal influenza A viruses that are directed toward the nucleoprotein. J. Infect. Dis. 215, 818\u2013823 (2017).","journal-title":"J. Infect. Dis."},{"key":"47590_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fimmu.2015.00329","volume":"6","author":"VV Mallajosyula","year":"2015","unstructured":"Mallajosyula, V. V. et al. Hemagglutinin sequence conservation guided stem immunogen design from influenza A H3 subtype. Front. Immunol. 6, 329 (2015).","journal-title":"Front. Immunol."},{"key":"47590_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.4049\/jimmunol.1602161","volume":"199","author":"MR McLean","year":"2017","unstructured":"McLean, M. R. et al. Dimeric Fcgamma receptor enzyme-linked immunosorbent assay to study HIV-specific antibodies: a new look into breadth of Fcgamma receptor antibodies induced by the RV144 vaccine trial. J. Immunol. 199, 816\u2013826 (2017).","journal-title":"J. Immunol."},{"key":"47590_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1608","volume":"2","author":"NM Stapleton","year":"2011","unstructured":"Stapleton, N. M. et al. Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat. Commun. 2, 599 (2011).","journal-title":"Nat. Commun."},{"key":"47590_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fimmu.2019.00553","volume":"10","author":"A Breedveld","year":"2019","unstructured":"Breedveld, A. & van Egmond, M. IgA and FcalphaRI: pathological roles and therapeutic opportunities. Front. Immunol. 10, 553 (2019).","journal-title":"Front. Immunol."},{"key":"47590_CR16","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nri2849","volume":"10","author":"MR Ehrenstein","year":"2010","unstructured":"Ehrenstein, M. R. & Notley, C. A. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10, 778\u2013786 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"47590_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13992-8","volume":"11","author":"U Steffen","year":"2020","unstructured":"Steffen, U. et al. IgA subclasses have different effector functions associated with distinct glycosylation profiles. Nat. Commun. 11, 120 (2020).","journal-title":"Nat. Commun."},{"key":"47590_CR18","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1086\/657311","volume":"51","author":"BJ Cowling","year":"2010","unstructured":"Cowling, B. J. et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin. Infect. Dis. 51, 1370\u20131379 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"47590_CR19","unstructured":"Seasonal Influenza Vaccine Effectiveness, 2018\u20132019 https:\/\/www.cdc.gov\/flu\/vaccines-work\/2018-2019.html (Center of Disease Control and Prevention, 2019)."},{"key":"47590_CR20","doi-asserted-by":"publisher","first-page":"e17713","DOI":"10.1371\/journal.pone.0017713","volume":"6","author":"Q Liao","year":"2011","unstructured":"Liao, Q., Cowling, B. J., Lam, W. W. & Fielding, R. Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study. PLoS ONE 6, e17713 (2011).","journal-title":"PLoS ONE"},{"key":"47590_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.13091","volume":"310","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt, D., Alter, G., Crotty, S. & Plotkin, S. A. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol. Rev. 310, 6\u201326 (2022).","journal-title":"Immunol. Rev."},{"key":"47590_CR22","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1586\/14760584.2014.922417","volume":"13","author":"KL Coelingh","year":"2014","unstructured":"Coelingh, K. L., Luke, C. J., Jin, H. & Talaat, K. R. Development of live attenuated influenza vaccines against pandemic influenza strains. Expert Rev. Vaccines 13, 855\u2013871 (2014).","journal-title":"Expert Rev. Vaccines"},{"key":"47590_CR23","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1093\/infdis\/jiz010","volume":"219","author":"JE Crowe","year":"2019","unstructured":"Crowe, J. E. Antibody determinants of influenza immunity. J. Infect. Dis. 219, S21\u2013S29 (2019).","journal-title":"J. Infect. Dis."},{"key":"47590_CR24","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1164\/rccm.201411-1988OC","volume":"191","author":"AC Hayward","year":"2015","unstructured":"Hayward, A. C. et al. Natural T cell-mediated protection against seasonal and pandemic influenza. Results of the Flu Watch Cohort Study. Am. J. Respir. Crit. Care Med. 191, 1422\u20131431 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"47590_CR25","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1128\/CVI.00397-07","volume":"15","author":"BD Forrest","year":"2008","unstructured":"Forrest, B. D. et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin. Vaccin. Immunol. 15, 1042\u20131053 (2008).","journal-title":"Clin. Vaccin. Immunol."},{"key":"47590_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7833","volume":"6","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+) T cells. Nat. Commun. 6, 6833 (2015).","journal-title":"Nat. Commun."},{"key":"47590_CR27","doi-asserted-by":"crossref","unstructured":"Dhakal, S. & Klein, S. L. Host factors impact vaccine efficacy: implications for seasonal and universal influenza vaccine programs. J. Virol. 93, e00797-19 (2019).","DOI":"10.1128\/JVI.00797-19"},{"key":"47590_CR28","doi-asserted-by":"publisher","unstructured":"Souquette, A. et al. Integrated drivers of basal and acute immunity in diverse human populations. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.03.25.534227 (2023).","DOI":"10.1101\/2023.03.25.534227"},{"key":"47590_CR29","unstructured":"Thomas, P. G. et al. Baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology. (Research Square, 2023)."},{"key":"47590_CR30","doi-asserted-by":"crossref","unstructured":"Meade, P. et al. Influenza virus infection induces a narrow antibody response in children but a broad recall response in adults. mBio 11, e03243-19 (2020).","DOI":"10.1128\/mBio.03243-19"},{"key":"47590_CR31","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1073\/pnas.1702173114","volume":"114","author":"T Li","year":"2017","unstructured":"Li, T. et al. Modulating IgG effector function by Fc glycan engineering. Proc. Natl Acad. Sci. USA 114, 3485\u20133490 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"47590_CR32","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/infdis\/jir015","volume":"203","author":"JG Petrie","year":"2011","unstructured":"Petrie, J. G., Ohmit, S. E., Johnson, E., Cross, R. T. & Monto, A. S. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J. Infect. Dis. 203, 1309\u20131315 (2011).","journal-title":"J. Infect. Dis."},{"key":"47590_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.chom.2018.07.009","volume":"24","author":"BM Gunn","year":"2018","unstructured":"Gunn, B. M. et al. A role for Fc function in therapeutic monoclonal antibody-mediated protection against Ebola virus. Cell Host Microbe 24, 221\u2013233.e225 (2018).","journal-title":"Cell Host Microbe"},{"key":"47590_CR34","doi-asserted-by":"publisher","first-page":"228ra239","DOI":"10.1126\/scitranslmed.3007730","volume":"6","author":"NL Yates","year":"2014","unstructured":"Yates, N. L. et al. Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Sci. Transl. Med. 6, 228ra239 (2014).","journal-title":"Sci. Transl. Med."},{"key":"47590_CR35","doi-asserted-by":"crossref","unstructured":"Zhang, A. et al. Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection. Nat. Rev. Immunol. 23:381\u2013396 (2022).","DOI":"10.1038\/s41577-022-00813-1"},{"key":"47590_CR36","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","volume":"366","author":"BF Haynes","year":"2012","unstructured":"Haynes, B. F. et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275\u20131286 (2012).","journal-title":"N. Engl. J. Med."},{"key":"47590_CR37","doi-asserted-by":"publisher","first-page":"228ra238","DOI":"10.1126\/scitranslmed.3007736","volume":"6","author":"AW Chung","year":"2014","unstructured":"Chung, A. W. et al. Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci. Transl. Med. 6, 228ra238 (2014).","journal-title":"Sci. Transl. Med."},{"key":"47590_CR38","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1097\/QAD.0000000000002976","volume":"35","author":"EW Nduati","year":"2021","unstructured":"Nduati, E. W. et al. Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination. AIDS 35, 1895\u20131905 (2021).","journal-title":"AIDS"},{"key":"47590_CR39","doi-asserted-by":"publisher","unstructured":"Carr, E. J. et al. Dichotomy of neutralizing antibody, B cell and T cell responses to SARS-CoV-2 vaccination and protection in healthy adults. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.05.24.541920 (2023).","DOI":"10.1101\/2023.05.24.541920"},{"key":"47590_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08036-6","volume":"10","author":"TK Tsang","year":"2019","unstructured":"Tsang, T. K. et al. Indirect protection from vaccinating children against influenza in households. Nat. Commun. 10, 106 (2019).","journal-title":"Nat. Commun."},{"key":"47590_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/srep22666","volume":"6","author":"SA Valkenburg","year":"2016","unstructured":"Valkenburg, S. A. et al. Stalking influenza by vaccination with pre-fusion headless HA mini-stem. Sci. Rep. 6, 22666 (2016).","journal-title":"Sci. Rep."},{"key":"47590_CR42","doi-asserted-by":"crossref","unstructured":"Lopez, E. et al. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight 6, e150012 (2021).","DOI":"10.1172\/jci.insight.150012"},{"key":"47590_CR43","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/bioinformatics\/btm069","volume":"23","author":"W Stacklies","year":"2007","unstructured":"Stacklies, W., Redestig, H., Scholz, M., Walther, D. & Selbig, J. pcaMethods-a bioconductor package providing PCA methods for incomplete data. Bioinformatics 23, 1164\u20131167 (2007).","journal-title":"Bioinformatics"},{"key":"47590_CR44","unstructured":"Kassambara, A. & Mundt, F. factoextra: extract and visualize the results of multivariate data analyses. https:\/\/CRAN.R-project.org\/package=factoextra (2020)."},{"key":"47590_CR45","doi-asserted-by":"publisher","first-page":"vey041","DOI":"10.1093\/ve\/vey041","volume":"5","author":"L Zhao","year":"2019","unstructured":"Zhao, L. & Illingworth, C. J. R. Measurements of intrahost viral diversity require an unbiased diversity metric. Virus Evol. 5, vey041 (2019).","journal-title":"Virus Evol."},{"key":"47590_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22236-7","volume":"12","author":"KJ Selva","year":"2021","unstructured":"Selva, K. J. et al. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat. Commun. 12, 2037 (2021).","journal-title":"Nat. Commun."}],"updated-by":[{"DOI":"10.1038\/s41467-024-52572-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47590-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T10:05:41Z","timestamp":1726740341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47590-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,13]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["47590"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-47590-0","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-024-52572-3","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,13]]},"assertion":[{"value":"7 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.J.C. has consulted for AstraZeneca, Fosun Pharma, GSK, Haleon, Moderna, Roche, and Sanofi Pasteur. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3210"}}